Larix Biosciences has developed a proprietary Antibody Membrane Switch (AMS) technology, which can be used for the isolation of production cell lines for therapeutic antibodies or other biological molecules. AMS technology can also be applied to antibody library screening. AMS permits assessment of critical product quality attributes besides production level during the earliest stages of cell line screening, reducing the complexity in downstream process development.
